Japan Society of Chemotherapy Unapproved Drug Issues Review Committee Advisory committee on high dose meropenem

Hiroshige Mikamo, Keiichi Mikasa, Satoshi Iwata, Katsunori Yanagihara

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Japan Society of Chemotherapy Unapproved Drug Issues Review Committee Advisory committee on high dose meropenem'. Together they form a unique fingerprint.

Medicine & Life Sciences